KalVista Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • KalVista Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$44.2M, a 52% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$156M, a 36.9% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$140M, a 26.7% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$111M, a 14.8% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$96.6M, a 66.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$140M -$29.6M -26.7% May 1, 2023 Apr 30, 2024 10-K 2024-07-11
2022 -$111M -$14.3M -14.8% May 1, 2022 Apr 30, 2023 10-K 2024-07-11
2021 -$96.6M -$38.7M -66.8% May 1, 2021 Apr 30, 2022 10-K 2024-07-11
2020 -$57.9M -$17.4M -42.9% May 1, 2020 Apr 30, 2021 10-K 2023-07-10
2019 -$40.5M -$10.7M -35.9% May 1, 2019 Apr 30, 2020 10-K 2022-07-07
2018 -$29.8M -$11.1M -59.4% May 1, 2018 Apr 30, 2019 10-K 2021-07-13
2017 -$18.7M +$3.63M +16.3% May 1, 2017 Apr 30, 2018 10-K 2020-07-01
2016 -$22.3M -$1.3M -6.19% May 1, 2016 Apr 30, 2017 10-K 2019-07-16
2015 -$21M -$9.36M -80.1% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 -$11.7M -$6.46M -124% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 -$5.22M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.